Anthony Bugembe and Elvis Basuude
26 August 2008
Kampala — UGANDA'S method of preventing HIV transmission from mother-to-child is not effective, AIDS activists have said.
Dr. Justine Nankinga, the national Anti-Reviral Therapy coordinator in the ministry of health, said in most developing countries, health workers administer only a single dose of nevirapine tablet to a mother at the onset of labour.
The single dose of nevirapine syrup is also administered to a newly-born baby 72 hours after birth. The baby also gets Zidocudine in addition to nevirapine.
This reduces HIV transmission by 50% if well administered, yet research has shown that if all HIV- positive pregnant women are given a triple combination of the ARVs, mother-to-child transmission can be reduced by 99%, Nakinga told participants at the second national HIV paedriatric conference in Kampala on Thursday.
"The country has been implementing the exercise for eight years but the measures we are using in Uganda don't reduce mother-to-child transmission."
Dr. Victor Tumusiime, a paediatrician, said: "Now that more resources are available, we are advocating for a triple combination. This is being done in other countries."
Be the first to Write a Comment!
Copyright © 2008 New Vision. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.
AllAfrica aggregates and indexes content from over 125 African news organizations, plus more than 200 other sources, who are responsible for their own reporting and views. Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica.
